Roche said that Christoph Franz has been reelected as chairman of the board. Nine other board members were also reelected to one-year terms, while two new board members were elected.
Rejoining Roche's board are André Hoffmann, Pius Baschera; John Bell; Paul Bulcke; DeAnne Julius; Andreas Oeri; Roche CEO Severin Schwan; Peter Voser; and Beatrice Weder di Mauro. Richard Lifton and Bernhard Poussot were elected as new board members.
Lifton is the Sterling Professor of Genetics and a professor of medicine at Yale University, where he is also chair of the genetics department. He is a Howard Hughes Medical Institute investigator.
Poussot is the former chairman and CEO of Wyeth and currently serves on the boards of other organizations including the Max Planck Institute.